CHILI 5.0
135:19CHILI 5.0
ImmunoPET in clinical decision guidance of immunotherapy
Maria Jose Garcia Velloso, Pamplona /ESP
Total body PET/CT – the game changer?
Axel Rominger, Bern /CH
How to set up a therapnostic center
Mike Sathekge, Pretoria /ZAF
AI in multimodality hybrid imaging
Irene Buvat, Orsay /FR
Discussion and Q&A with the experts
Moderation: Clemens Cyran & Thomas Beyer
108:23CHILI 5.0
PET/CT for Radiation Therapy Planning
Danijela Dejanovic, Copenhagen /DK
FDG PET/CT for monitoring immunotherapy
Egesta Lopci, Rozzano /IT
Therapeutic management of lymphoma including with PET/CT (incl. CAR-T)
Marcus Unterrainer, Munich /DE
Breast Cancer therapy guidance with FDG PET/CT
Katja Pinker-Domenig, New York /US
Discussion and Q&A with the experts
Moderation: Clemens Cyran & Thomas Beyer
106:14CHILI 5.0
An update on novel developments in hybrid imaging of infection and inflammation
Ora Israel, Haifa /ISR
Hybrid imaging in inflammatory diseases
Jose Vercher Conejero, Barcelona /ESP
Bone SPECT/CT in orthopedics
Klaus Strobel, Lucerne /CH
TAU PET/MR in dementia
Alexander Hammers, United Kingdom
Discussion and Q&A with the experts
Moderation: Clemens Cyran & Thomas Beyer
31:20CHILI 5.0
Radiation Dose Reduction and Dose Optimisation in PET Imaging
Ana Matos, United Kingdom
Discussion and Q&A
109:31CHILI 5.0
Theranostics in NET – State of the art and future perspectives
Harun Ilhan, Munich /DE
FAPI in oncologic imaging – the next FDG?
Frederik Giesel, Heidelberg /DE
Hybrid imaging and theranostics in meningeoma
Betty Salgues, France
Prospective studies in prostate cancer therapy guidance by PSMA PET/CT
Jeremie Calais, Santa Monica /US
Discussion and Q&A with the experts
Moderation: Clemens Cyran & Thomas Beyer